Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-FU, and infusional 5-FU alone in advanced pancreatic carcinoma patients-Reference-Cited by-同舟云学术

Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-FU, and infusional 5-FU alone in advanced pancreatic carcinoma patients

Published:2004-03 Issue:3 Volume:15 Page:467-473
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Ducreux M.,Mitry E.,Ould-Kaci M.,Boige V.,Seitz J.F.,Bugat R.,Breau J.L.,Bouché O.,Etienne P.L.,Tigaud J.M.,Morvan F.,Cvitkovic E.,Rougier P.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/15/3/467/558247/mdh098.pdf

Reference34 articles.

1. Cancer in the European Community and its member states;Jensen;Eur J Cancer,1990

2. Cancer of the pancreas: diagnostic, accuracy and survival statistics;Gudjonsson;Cancer,1978

3. The National Cancer Data Base report on pancreatic cancer;Niederhuber;Cancer,1995

4. Improvement in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial;Burris;J Clin Oncol,1997

5. A phase III trial on the therapy of advanced pancreatic carcinoma. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin and cisplatin;Cullinan;Cancer,1990

Cited by 88 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Folfirinox vs. Gemcitabine + Nab-Paclitaxel as the First-Line Treatment for Pancreatic Cancer: A Systematic Review and Meta-Analysis;World Journal of Oncology;2023-10

2. Optimizing First-Line Chemotherapy in Metastatic Pancreatic Cancer: Efficacy of FOLFIRINOX versus Nab-Paclitaxel Plus Gemcitabine;Cancers;2023-01-08

3. Treatment of unresectable locally advanced pancreatic cancer with percutaneous irreversible electroporation (IRE) following initial systemic chemotherapy (LAP-PIE) trial: study protocol for a feasibility randomised controlled trial;BMJ Open;2022-05

4. Application of Approved Cisplatin Derivatives in Combination Therapy against Different Cancer Diseases;Molecules;2022-04-11

5. Meta-analysis and indirect treatment comparison of modified FOLFIRINOX and gemcitabine plus nab-paclitaxel as first-line chemotherapy in advanced pancreatic cancer;BMC Cancer;2021-07-23